China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. provides unaudited earnings guidance for the three months ending March 31, 2021. For the period, the company estimates to increase from approximately RMB 541.91 million to approximately RMB 600 million to RMB 710 million, representing year-on-year increase of approximately 10.72% to 31.02%.